The case for developing consensus standards for research in microbial pathogenesis: Bacillus anthracis toxins as an example

Infection and Immunity

Volumn 77, Issue 10, 2009, Pages 4182-4186

  Hughes, Molly A ^a   Burns, Drusilla L ^b   Juris, Stephen J ^c   Tang, Wei Jen ^d   Clement, Kristin H ^e   Eaton, Linda J ^f   Kelly Cirino, Cassandra D ^g   McKee, Marian L ^h   Powell, Bradford S ⁱ   Bishop, Brian L ^d   Rudge, Thomas L ^e   Shine, Nancy ^f   Verma, Anita ^b   Willis, Melissa Swope ^h   Morse, Stephen A ^j  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c CENTRAL MICHIGAN UNIVERSITY   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e BATTELLE MEMORIAL INSTITUTE   (United States)

^f List Biological Laboratories Inc   (United States)

^g WADSWORTH CENTER   (United States)

^h ATCC   (United States)

ⁱ UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^j NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; BOTULINUM TOXIN A;

ANTHRAX; BACILLUS ANTHRACIS; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CHLAMYDOPHILA PNEUMONIAE; CONSENSUS DEVELOPMENT; GENE EXPRESSION PROFILING; IMMUNE RESPONSE; IMMUNOASSAY; INFECTION PREVENTION; MEDICAL RESEARCH; NONHUMAN; NOTE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTHRAX; BIOMEDICAL RESEARCH; CONSENSUS; HUMANS; REFERENCE STANDARDS;

EID: 70349423529     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00368-09     Document Type: Note

References (31)

1. Arnon, S. S., R. Schecter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, J. Hauer, M. Layton, S. Lillibridge, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, D. L. Swerdlow, K. Tonat, et al. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA 285:1059-1070. (Pubitemid 32176420)
2. Ashburner, M., C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A. P. Davis, K. Dolinski, S. S. Dwight, J. T. Eppig, M. A. Harris, D. P. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. C. Matese, J. E. Richardson, M. Ringwald, G. M. Rubin, G. Sherlock, et al. 2000. Gene Ontology: tool for the unification of biology. Nat. Genet. 25:25-29.
3. Bergman, N. H., K. D. Passalacqua, R. Gaspard, L. M. Shetron-Rama, J. Quackenbush, and P. C. Hanna. 2005. Murine transcriptional responses to Bacillus anthracis infection and intoxication. Infect. Immun. 73:1069-1080.
4. Boman, J., and M. R. Hammerschlag. 2002. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin. Microbiol. Rev. 15:1-20.
5. Borio, L., T. Inglesby, C. J. Peters, A. L. Schmaljohn, J. M. Hughes, P. B. Jahrling, T. Ksiazek, K. M. Johnson, A. Meyerhoff, T. O'Toole, M. S. Ascher, J. Bartlett, J. G. Breman, E. M. Eitzen, Jr., M. Hamburg, J. Hauer, D. A. Henderson, R. T. Johnson, G. Kwik, M. Layton, S. Lillibridge, G. J. Nabel, M. T. Osterholm, T. M. Perl, P. Russell, K. Tonat, et al. 2002. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287:2391-2405. (Pubitemid 34493202)
6. Boyden, E. D., and W. F. Dietrich. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38:240-244.
7. Brazma, A. 2001. On the importance of standardisation in life sciences. Bioinformatics 17:113-114.
8. Brooksbank, C., and J. Quackenbush. 2006. Data standards: a call to action. OMICS 10:94-99.
9. Chen, K. H., S. Liu, L. A. Bankston, R. C. Liddington, and S. H. Leppla. 2007. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells. J. Biol. Chem. 282:9834-9845.
10. Comer, J. E., C. L. Galindo, A. K. Chopra, and J. W. Peterson. 2005. GeneChip analyses of global transcriptional responses of murine macrophages to the lethal toxin of Bacillus anthracis. Infect. Immun. 73:1879-1885.
11. Dennis, D. T., T. V. Inglesby, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, M. Layton, S. R. Lillibridge, J. E. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, K. Tonat, et al. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285:2763-2773. (Pubitemid 32525374)
12. Deshpande, A., R. J. Hammon, C. K. Sanders, and S. W. Graves. 2006. Quantitative analysis of the effect of cell type and cellular differentiation on protective antigen binding to human target cells. FEBS Lett. 580:4172-4175. (Pubitemid 44037587)
13. Field, D., and S.-A. Sansone. 2006. Foreword: a special issue on data standards. OMICS 10:84-93. (Pubitemid 44298594)
14. Firoved, A. M., G. F. Miller, M. Moayeri, R. Kakker, Y. Shen, J. F. Wiggins, E. M. McNally, W.-J. Tang, and S. H. Leppla. 2005. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 167:1309-1320.
15. Harris, M. A., J. I. Clark, A. Ireland, J. Lomax, M. Ashburner, R. Collins, K. Eilbeck, S. Lewis, C. Mungall, J. Richter, G. M. Rubin, S. Q. Shu, J. A. Blake, C. J. Bult, A. D. Diehl, M. E. Dolan, H. J. Drabkin, J. T. Eppig, D. P. Hill, L. Ni, M. Ringwald, R. Balakrishnan, G. Binkley, J. M. Cherry, K. R. Christie, M. C. Costanzo, Q. Dong, S. R. Engel, D. G. Fisk, J. E. Hirschman, B. C. Hitz, E. L. Hong, C. Lane, S. Miyasato, R. Nash, A. Sethuraman, M. Skrzypek, C. L. Theesfeld, S. A. Weng, D. Botstein, K. Dolinski, R. Oughtred, T. Berardini, S. Mundodi, S. Y. Rhee, R. Apweiler, D. Barrell, E. Camon, E. Dimmer, N. Mulder, R. Chisholm, P. Fey, P. Gaudet, W. Kibbe, K. Pilcher, C. A. Bastiani, R. Kishore, E. M. Schwarz, P. Sternberg, K. Van Auken, M. Gwinn, L. Hannick, J. Wortman, M. Aslett, M. Berriman, V. Wood, S. Bromberg, C. Foote, H. Jacob, D. Pasko, V. Petri, D. Reilly, K. Seiler, M. Shimoyama, J. Smith, S. Twigger, P. Jaiswal, T. Seigfried, C. Collmer, D. Howe, M. Westerfield, et al. 2006. The Gene Ontology (GO) project in 2006. Nucleic Acids Res. 34:D322-D326.
16. Inglesby, T. V., T. O'Toole, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. M. Friedlander, J. Gerberding, J. Hauer, J. Hughes, J. McDade, M. T. Osterholm, G. Parker, T. M. Perl, P. K. Russell, K. Tonat, et al. 2002. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 287:2236-2252.
17. Inglesby, T. V., D. T. Dennis, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, J. F. Koerner, M. Layton, J. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, M. Schoch-Spana, K. Tonat, et al. 2000. Plague as a biological weapon: medical and public health management. JAMA 283:2281-2290.
18. Li, H., S. D. Soroka, T. H. Taylor, Jr., K. L. Stamey, K. W. Stinson, A. E. Freeman, D. R. Abramson, R. Desai, L. X. Cronin, J. W. Oxford, J. Caba, C. Pleatmean, S. Pathak, D. S. Schmidt, V. A. Semenova, S. K. Martin, P. W. Wilkins, and C. P. Quinn. 2008. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization. J. Immunol. Methods 333:89-106.
19. McLellan, K., R. E. Gaines Das, T. A. N. Ekong, and D. Sesardic. 1996. Therapeutic botulinum type A toxin: factors affecting potency. Toxicon 34:975-985. (Pubitemid 26320008)
20. Murchan, S., M. E. Kaufmann, A. Deplano, R. de Ryck, M. Struelens, C. E. Zinn, V. Fussing, S. Salmenlinna, J. Vupio-Varkila, N. El Soth, C. Cuny, W. Witte, P. Y. Tassios, N. Legakis, W. van Leeuwen, A. van Belkum, A. Vindel, I. Laconcha, J. Garaizar, S. Haeggman, B. Olsson-Liljequist, U. Ransjo, G. Coombs, and B. Cookson. 2003. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J. Clin. Microbiol. 41:1574-1585.
21. Omland K. S., A. Brys, D. Lansky, K. Clement, F. Lynn, et al. 2008. Interlaboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species. Clin. Vaccine Immunol. 15:946-953.
22. Preneta-Blanc, R., P. Rigsby, E. S Wilhelmsen, R. Tierney, M. Brierley, and D. Sesardic. 2008. Calibration of replacement international standards of diphtheria and tetanus toxoids for use in flocculation test. Biologicals 36:315-326.
23. Quackenbush, J. 2004. Data standards for 'omic' science. Nat. Biotechnol. 22:613-614.
24. Rainey, G. J. A., D. J. Wigelsworth, P. L. Ryan, H. M. Scobie, R. J. Collier, and J. A. T. Young. 2005. Receptor-specific requirements for anthrax toxin delivery into cells. Proc. Natl. Acad. Sci. USA 102:13278-13283.
25. Sapra, R., S. P. Gaucher, J. S. Lachmann, G. M. Buffleben, G. S. Chirica, J. E. Comer, J. W. Peterson, A. K. Chopra, and A. K. Singh. 2006. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin. Microb. Pathog. 41:157-167.
26. Sesardic, D., T. Leung, and D. R. Gaines. 2003. Role of standards in assays of botulinum toxins. International study of three preparations of botulinum type A toxin. Biologicals 31:265-276.
27. Stephenson, E. L., P. R. Braude, and C. Mason. 2007. International community consensus standard for reporting derivation of human embryonic stem cell lines. Regen. Med. 2:349-362.
28. Struelens, M. J., P. M. Hawkey, G. L. French, W. Witte, and E. Tacconelli. 2009. Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. Clin. Microbiol. Infect. 15:112-119.
29. Tondella, M. L., G. M. Carlone, N. Messonnier, C. P. Quinn, B. D. Meade, D. L. Burns, J. D. Cherry, N. Guiso, E. L. Hewlett, K. M. Edwards, D. Xing, A. Giammanco, C. H. Wirsing von Konig, L. Han, L. Hueston, J. B. Robbins, M. Powell, C. M. Mink, J. T. Poolman, S. W. Hildreth, F. Lynn, and A. Morris. 2009. International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007. Vaccine 27:803-814.
30. Turk, B. E. 2007. Manipulation of host signaling pathways by anthrax toxins. Biochem. J. 402:405-417. (Pubitemid 46423878)
31. Voth, D. E., E. E. Hamm, L. G. Nguyen, A. E. Tucker, I. I. Salles, W. Ortiz-Leduc, and J. D. Ballard. 2005. Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell. Microbiol. 7:1139-1149.